Note: Ingredients listed on restricted chemical lists
EC/CAS
57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
N/A
EC/CAS
93-14-1
Name of the chemical
Guaifenesin (INN)
Concentration
N/A
EC/CAS
200-334-9
Name of the chemical
Sucrose, pure C12H22O11
Concentration
N/A
EC/CAS
202-222-5
Name of the chemical
Guaifenesin (INN)
Concentration
N/A
General Information
Revision date
2018-05-14
Product name
LINCTIFED EXPECTORANT SYRUP
Product Synonyms
LINCTIFED EXPECTORANT SYRUP 10/100/30/2 MG/5 ML * LINCTIFED EXPECTORANT
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
Section 2
EU Classification
Directive 67/548/EEC or 1999/45/EC as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device. Regulation (EC) No 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.3 Other hazards
This product will support combustion at elevated temperatures. Caution - Pharmaceutical agent. See section 11 for additional information on health hazards.
